Kirkov Kirko bought ELTP
July 10, 2025 · Form 4 insider transaction
Kirkov Kirko bought 16,366 shares of Elite Pharmaceuticals, Inc. at $0.59 per share, a transaction worth $9.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 15 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,366
Price
$0.59
Total value
$9.6K
InsiderKirkov Kirko
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJuly 10, 2025
Filing dateJuly 25, 2025
Shares owned after16,366
OwnershipDirect
10b5-1 planNo
AmendedNo